Skip to content

Author

Ismail Erturk

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Prognostic role of HER2-low expression in HR +/HER2- metastatic breast cancer treated with CDK4/6 inhibitors

The low expression of human epidermal growth factor receptor 2 (HER2) in hormone receptor positive (HR +) metastatic breast cancer has become a novel area of interest, particularly after the demonstration that it can be targeted with antibody–drug conjugates (ADCs). This study aimed to describe the clinicopathological...

Gül Sema Yildiran Keskin, Gizem Yıldırım, M. Aykan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.